Olivier Pâris

Associate, Paris
[email protected]

Biography

Overview

Olivier Pâris is an associate in the Corporate/Mergers & Acquisitions department of White & Case in Paris.

He is involved in corporate transactions in all manner of M&A, including public and private M&A deals, sales and joint ventures primarily belonging to the jumbo-cap to mid-cap market segments. Olivier also advises clients in connection with corporate governance, market abuse and insider dealing issues.

Olivier is at ease working on domestic and cross-border mergers and acquisitions on behalf of multinational clients, including investment banks, entrepreneurs, industrials, listed, and non-listed companies, from all sectors, in particular in the automotive, financial, banking and energy and infrastructure sectors.

Prior to joining White & Case in 2020, Olivier practiced in the Paris office of a Magic Circle law firm for six years.

Bars and Courts
Paris Bar
Education
Post-Master's Degree
Financial & Business Law
University of Paris XI Sceaux
Master's Degree
Business Law
Panthéon-Assas University
Certificate
Banking and Tax law
Panthéon-Assas University
Master's Degree
Corporate Finance
École supérieure de commerce de Reims

(NEOMA Business School)

Languages
French
English

Experience

Mergers & Acquisitions
Pharmaceuticals & Healthcare

Olivier has advised on significant corporate transactions, including:

  • Pegasus Entrepreneurs and its sponsors Tikehau Capital, Financière Agache, CEO Pierre Cuilleret, Jean-Pierre Mustier and Diego De Giorgi in connection with its de-SPACing with FL Entertainment, a global entertainment group comprising Banijay Group and Betclic Everest Group, that will result in the listing of FL Entertainment on Euronext Amsterdam.
  • Representation of Biosynex, on:
    • its tender offer for all of the shares of Chembio Diagnostics, Inc., a U.S. biotechnology corporation listed on Nasdaq;
    • the acquisition of the brand "Para'kito", the European leader in the prevention and treatment of mosquito bites with 100% natural formulas, its active ingredients and its IP (patents and trademarks);
    • the acquisition of Enalees' business going concern relating to medical diagnostic products;
    • the sale of a business going concern to ELITech Microbio relating to medical diagnostic products.
  • RTL Group in connection with the proposed combination between Groupe TF1 and Groupe M6.
  • Caisse des Dépôts et Consignations on the sale of its minority stakes held in three biomass plants (Kogeban, Cogénération Biomasse d'Estrées-Mons et Cogénération Biomasse de Novillars) to PEARL Infrastructure Capital.
  • Idex on its acquisition of a biomass power generation plant and its operating company*.
  • Engie on the agreement with EDPR to create a co-controlled 50/50 joint-venture in fixed and floating offshore wind*.
  • Engie New Business on the investment in tiko Energy Solutions AG*.
  • RP Global on the sale of portfolios companies of wind farms projects to EDPR*.
  • SIX Group AG in relation to the signing of a strategic partnership with Worldline SA. This operation consisted in the contribution by SIX Group of its payment services division to Worldline SA*.
  • Sonnedix on the acquisition of portfolio companies owning and operating photovoltaic power plants*.
  • BNP Paribas and BNP Paribas Personal Finance, on the acquisition of OPEL/Vauxhall's captive financing activities and the set-up of a long-term strategic partnership with PSA*.

*Transactions worked on prior to joining White & Case

Related Content